Effect of ischemic preconditioning of the myocardium on cAMP

Circulation Research

Volumn 78, Issue 1, 1996, Pages 137-147

  Sandhu, Reena ^a   Thomas, Usha ^b   Diaz, Roberto J ^b   Wilson, Gregory J ^b  

^a TORONTO GENERAL HOSPITAL   (Canada)

^b NONE

Author keywords

adenylyl cyclase; cAMP; ischemia; myocardial infarction; preconditioning

Indexed keywords

6 (3 DIMETHYLAMINOPROPIONYL)FORSKOLIN; ADENYLATE CYCLASE; CYCLIC AMP; ISOPRENALINE; POLYMYXIN B; PROTEIN KINASE C;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; DRUG EFFECT; ENZYME ACTIVATION; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; NONHUMAN; NORADRENALIN RELEASE; PHOSPHATE METABOLISM; PRIORITY JOURNAL; RABBIT; SIGNAL TRANSDUCTION;

EID: 0030038790     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.78.1.137     Document Type: Article

References (36)

1. Reimer KA, Vander Heide RS, Murry CE, Jennings RB. Role of altered energy metabolism in ischemic preconditioning. In: Przyklenk K, Kloner R, Yellon D, eds. Ischemic Preconditioning: The Concept of Endogenous Cardioprotection. Norwell, Mass: Kluwer Academic Publishing; 1994:75-103.
2. Szilvassy Z, Ferdinandy P, Bor P, Jakab I, Lonovics J, Koltai M. Ventricular overdrive pacing-induced anti-ischemic effect: a conscious rabbit model of preconditioning. Am J Physiol. 1994;266: H2033-H2041.
3. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol. 1994;266: H1145-1152.
4. Mitchell MB, Meng X, Ao L, Brown JM, Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res. 1995;76:73-81.
5. Houslay MD. 'Crosstalk': a pivotal role for protein kinase C in modulating relationships between signal transduction pathways. Eur J Biochem. 1991;195:9-27.
6. Roth NS, Campbell PT, Caron MG, Lefkowitz RJ, Lohse MJ. Comparative rates of desensitization of β-adrenergic receptors by the β-adrenergic receptor kinase and the cyclic AMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1991;88:6201-6204.
7. Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ. b-Arrestin: a protein that regulates beta-adrenergic receptor function. Science. 1990;248:1547-1550.
8. Schömig A. Catecholamines in myocardial ischemia: systemic and cardiac release. Circulation. 1990;82(suppl 2):II-13-II-22.
9. Seyfarth M, Münch G, Schreieck J, Kurz T, Richardt G, Schömig A. Release of norepinephrine is suppressed by preconditioning in rat ischemic hearts. Circulation. 1994;90(suppl 1):I-108. Abstract.
10. Martorana PA. The role of cyclic AMP in isoprenaline induced cardiac necroses in the rat. J Pharm Pharmacol. 1971;23:200-203.
11. Ebbesen P. Myocardial degeneration in mice treated with dibutyryl cAMP and or theophylline. Virchows Arch A Pathol Anat Histopathol. 1976;372:89-95.
12. Tsien R. Calcium channels in excitable cell membranes. Annu Rev Physiol. 1983;45:341-358.
13. Opie LH. Role of cyclic nucleotides in heart metabolism. Cardiovasc Res. 1982;16:483-507.
14. 1-selective adenosine analogues protects the heart against infarction. Circulation. 1992;85:659-665.
15. Thornton JD, Liu GS, Downey JM. Pretreatment with pertussis toxin blocks the protective effects of preconditioning: evidence for a G-protein mechanism. J Mol Cell Cardiol. 1993;25:311-320.
16. Gilman AG. G proteins and dual control of adenylate cyclase. Cell. 1984;36:577-579.
17. Kubalak SW, Newman WH, Webb JG. Differential effect of pertussis toxin on adenosine and muscarinic inhibition of cyclic AMP accumulation in canine ventricular myocytes. J Mol Cell Cardiol. 1991;23:199-205.
18. Steiner AL, Wehmann RE, Parker CW, Kipnis DM. Radioimmunoassay for the measurement of cyclic nucleotides. Adv Cyclic Nucleotide Res. 1972;2:51-61.
19. i-2 and the phosphorylation and stimulation of a specific cyclic AMP phosphodiesterase. In: Konijn T, Houslay M, Van Haastert P, eds. Activation and Desensitization of Transducing Pathways. Berlin, Germany: Springer-Verlag; 1990;44: 63-83. NATO ASI Series.
20. Strasser RH, Kimmer J, Braun-Dullaeus R, Marquetant R, Kubler W. Dual sensitization of the adrenergic system in early myocardial ischemia: independent regulation of the β-adrenergic receptors and the adenylyl cyclase. J Mol Cell Cardiol. 1990;22:1405-1423.
21. 1-Receptor-independent activation of protein kinase C in acute myocardial ischemia: mechanisms for sensitization of the adenylyl cyclase system. Circ Res. 1992;70:1304-1312.
22. Iwase T, Murakami T, Tomita T, Miki S, Nagai K, Sasayama S. Ischemic preconditioning is associated with a delay in ischemia-induced reduction of β-adrenergic signal transduction in rabbit hearts. Circulation. 1993;88:2827-2837.
23. Niroomand F, Weinbrenner C, Weis A, Bangert M, Schwencke C. Marquetant R, Beyer T, Strasser RH, Kübler W, Rauch B. Impaired function of inhibitory G proteins during acute myocardial ischemia of canine hearts and its reversal during reperfusion and a second period of ischemia: possible implications for the protective mechanism of ischemic preconditioning. Circ Res. 1995;76:861-870.
24. Ogawa K, Nakamura T. Effect of propranolol on cyclic nucleotides of ischemic dog heart. In: Tajuddin M, Bhatia B, Siddiqui H, Rona G, eds. Advances in Myocardiology. Baltimore, Md: University Park Press; 1980;2:449-4455.
25. Corr PB, Witkowski FX, Sobel BE. Mechanisms contributing to malignant dysrhythmias induced by ischemia in the cat. J Clin Invest. 1978;61:109-119.
26. Shahab L, Wollenberger A, Krause EG, Genz S. Changes in catecholamine mobilization and cyclic AMP levels in normal and hypertrophied rat heart. In: Oliver M, Julian D, Donald K, eds. Effect of Acute Ischemia on Myocardial Function. London, England: Churchill Livingstone; 1972:97-107.
27. 1-adrenergic mechanism. Circ Res. 1993;73:656-670.
28. Miyazaki T, Zipes DP. Protection against autonomic denervation following acute myocardial infarction by preconditioning ischemia. Circ Res. 1989;64:437-448.
29. Hosono M, Takahira T, Fujita A, Fujihara R, Ishizuka O, Tatee T, Nakamura K. Cardiovascular and adenylate cyclase stimulant properties of NKH477, a novel water-soluble forskolin derivative. J Cardiovasc Pharmacol. 1992;19:625-634.
30. Sandhu R, Diaz RJ, Wilson GJ. Raising cAMP levels using forskolin pretreatment does not block ischemic preconditioning. J Mol Cell Cardiol. 1994;26:136. Abstract.
31. Lawson CS, Hearse DJ. Preconditioning and ischemia- and reperfusion-induced arrhythmias. In: Przyklenk K, Kloner R, Yellon D, eds. Ischemic Preconditioning: The Concept of Endogenous Cardioprotection. Norwell, Mass: Kluwer Academic Publishers; 1994:19-40.
32. Cohen MV, Yang X-M, Downey JM. Conscious rabbits become tolerant to multiple episodes of ischemic preconditioning. Circ Res. 1994;74:998-1004.
33. Lubbe WF, Podzuweit T, Opie LH. Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodies-terase inhibitors. J Am Coll Cardiol. 1992;19:1622-1633.
34. Opie LH, Muller C, Nathan D, Daries P, Lubbe WF. Evidence for role of cyclic AMP as second messenger of arrhythmogenic effects of beta-stimulation. Adv Cyclic Nucleotide Res. 1980;12:63-69.
35. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C: its role in ischemic preconditioning in the rat. Circ Res. 1994;75: 586-590.
36. Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation. 1990;82:609-619.